Building a better world

Europe’s most successful science park

A vibrant community of like-minded people

Combining science and nature

Visiting the park

Tuesday 21th August

14°

Wednesday 22th August

13°

Thursday 23th August

10°

Friday 24th August

9°

Visiting a company?

Find it on our interactive map

Next bus departing

N - St Ives

Leaving The Busway Science Park

1 min

A - Trumpington, Cambridge

Leaving The Busway Science Park

7 mins

A - St Ives

Leaving The Busway Science Park

8 mins

C - Cambridge

Leaving The Busway Science Park

15 mins

Next train departing

11:21 - London Liverpool Street

Leaving Cambridge

1 min

11:22 - Cambridge North

Leaving Cambridge

2 mins

11:27 - London Kings Cross

Leaving Cambridge

7 mins

11:30 - Stansted Airport

Leaving Cambridge

10 mins

About the Cambridge Science Park

The Cambridge Science Park was established 48 years ago when Trinity College Cambridge embraced the concept that would change the hi-tech sector in Cambridge, the UK and beyond. Trinity owns the freehold of the Cambridge Science Park, which today comprises 150 acres, 1.7 million sq ft of high technology and laboratory buildings. It’s home to 6500 people at over 100 companies, ranging from exciting start-ups to some of the world's leading technology businesses.

Over 100 entrepreneurial businesses

Companies and entrepreneurs at the Cambridge Science Park are working on life-enhancing technologies, ranging from non-invasive diagnostics and novel medicines to next-generation display and communications technologies, to name just a few. The wide range of occupiers in terms of size, sector, age and nationality offers unrivalled opportunities for collaboration, innovation and inspiration.

The latest news, discoveries and innovations

See all news

TWEET by @Agenus_Bio

Agree @breelynwilky! $AGEN actively pursuing #immunotherapy in solid tumors; We presented @ASCO 2018 - one of our patients w #angiosarcoma, experienced sustained complete response with our proprietary anti-#CTLA4 (AGEN 1884), in a phase 1 trial @SylvesterCancer #oncology twitter.com/breelynwilky/s…